Gynecologic Oncology
RSSArticles
-
Report: Record Year-Over-Year Decline in Cancer Death Rate
Fewer smokers, better detection and treatment methods credited with saving lives.
-
PARP Inhibitors: An Adjunct to Initial Standard Treatment for Advanced Ovarian Cancer Patients
The PRIMA study is a randomized, double-blind, multi-institutional, international phase 3 trial testing the PARP inhibitor niraparib against placebo after first-line standard treatment with platinum-based chemotherapy for newly diagnosed ovarian cancer.
-
Educate Patients on Link Between HPV and Anal, Penile, Oral Cancers
Results of a new analysis led by researchers at The University of Texas Health Science Center at Houston indicate that more than 70% of U.S. adults do not know that human papillomavirus causes anal, penile, and oral cancers.
-
Women’s Health Clinic Closures Affect Cervical Cancer Markers
Results of a recent analysis indicate that more women were diagnosed with advanced stages of cervical cancer, mortality rates increased, and fewer women were screened for the disease following the closure of nearly 100 women’s health clinics across the United States from 2010 to 2013.
-
Intrauterine Device Use and Ovarian Cancer Risk
In this systematic review, the odds ratio of ever-use of an intrauterine device and incident ovarian cancer was 0.68 (95% CI 0.62-0.75).
-
Molecular Analysis of Endometrial Cancer Corresponds With Outcomes in Young Women
SYNOPSIS: In this retrospective cohort study, researchers studied the prognosis and outcomes for young women with endometrial cancer and compared them according to tumor molecular classification.
-
Changes in Cervical Cancer Staging
This paper is an epidemiologic validation of recent changes in cervical cancer staging.
-
Pregnancy Temporarily Increases Breast Cancer Risk: Parallels to Hormonal Contraception?
In a pooled analysis of prospective studies, researchers found an increased risk of breast cancer among parous women that persists for more than 20 years after childbirth. Breastfeeding did not modify this pattern.
-
Intrauterine Devices and Cervical Cancer
In this case-control study, levonorgestrel IUD use was associated with a slightly increased rate of CIN 2 but not CIN 3. Copper IUD use was not associated with CIN 2 or CIN 3.
-
Primary HPV Screening: Ready for Prime Time?
In this randomized, controlled trial of more than 25,000 women, participants with negative high-risk human papillomavirus testing at baseline had rates of CIN 3+ at 48 months that were lower compared to negative liquid-based cytology testing.